Sharp Shalini

CIK 000137720211 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001377202

Recent Transactions

50 trades

Award
Septerna, Inc.$SEPN
Stock Option (Right to Buy)
2025-06-17+16,623→ 16,623 total
Award
Organon & Co.$OGN
Phantom Stock
2025-06-13$10.04/sh+23,904.382→ 63,054.148 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-22−1,435→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-05-22+1,435→ 2,429 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-05-21+3,305→ 3,305 total
Award
BeOne Medicines Ltd.$ONC
Ordinary Shares
2025-05-21+10,985→ 19,136 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-21+1,659→ 1,659 total
Award
BeOne Medicines Ltd.$ONC
Share Option (Right to Buy)
2025-05-21+22,750→ 22,750 total
Award
BeOne Medicines Ltd.$ONC
Ordinary Shares
2024-09-30+8,151→ 8,151 total
Award
BeOne Medicines Ltd.$ONC
Share Option (Right to Buy)
2024-09-30+17,238→ 17,238 total
Award
Organon & Co.$OGN
Phantom Stock
2024-06-07$20.75/sh+9,638.554→ 36,783.9 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-05-22+2,982→ 2,982 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-22+1,435→ 1,435 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-17−2,100→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-17$141.90/sh−1,106→ 994 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-17+2,100→ 2,100 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−4,162→ 12,060 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−6,808→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−7,520→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−5,252→ 6,808 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-12-29$58.75/sh+6,808→ 16,222 total
Award
Organon & Co.$OGN
Phantom Stock
2023-06-09$19.83/sh+10,086→ 25,594 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-05-17+4,290→ 4,290 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2023-05-17+2,100→ 2,100 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-01-20+4,444→ 9,414 total
Award
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
2023-01-20+7,520→ 7,520 total
Award
Organon & Co.$OGN
Phantom Stock
2022-06-10$35.46/sh+5,640→ 14,935 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2022-06-06+18,500→ 18,500 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2022-05-18+9,724→ 9,724 total
Award
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
2022-01-14+3,688→ 3,688 total
Award
Mirati Therapeutics, Inc.
Common Stock
2022-01-14+2,546→ 4,970 total
Award
Organon & Co.$OGN
Phantom Stock
2021-06-04$36.05/sh+9,061→ 9,061 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2021-06-03+18,500→ 18,500 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2021-05-19+8,833→ 8,833 total
Award
PRECISION BIOSCIENCES INC$DTIL
Stock Option (Right to Buy)
2021-05-10+32,800→ 32,800 total
Award
Mirati Therapeutics, Inc.
Common Stock
2021-03-26+2,424→ 2,424 total
Award
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
2021-03-26+3,523→ 3,523 total
Award
Nuvation Bio Inc.$NUVB
Class A Common Stock
2021-02-10$10.00/sh+10,000→ 35,000 total
Exercise/Conversion
Nuvation Bio Inc.$NUVB
Class A Common Stock
2021-02-10+25,000→ 25,000 total
Exercise/Conversion
Nuvation Bio Inc.$NUVB
Class B Common Stock
2021-02-10−25,000→ 0 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-10-14$87.99/sh−375→ 97,812 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-08-17$67.55/sh+7,188→ 105,375 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-08-17$88.54/sh−2,560→ 98,187 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2020-08-17−500→ 0 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-08-17$48.43/sh+3,669→ 101,856 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2020-08-17−7,188→ 15,812 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-08-17$88.38/sh−500→ 98,187 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-08-17$70.57/sh+500→ 98,687 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-08-17$88.38/sh−7,188→ 98,187 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-08-17$88.24/sh−461→ 100,747 total

Sharp Shalini

Recent Transactions

Companies

Recent Filings

Address